Home
Home
News Feed
Free Newsletters
Medical News 'Tweets'
Talk Medical
News A-Z
Business / Finance
Child Health News
Device / Technology News
Disease/Infection News
Drug Trial News
Healthcare News
Medical Condition News
Medical Patent News
Medical Procedure News
Medical Research News
Medical Science News
Men's Health News
Miscellaneous News
Pharmaceutical News
Women's Health News
Alzheimer's
Arthritis
Asthma
Autism
Blood Pressure
Breast Cancer
Cancer
Cardiovascular Disease
Cellulitis
Cerebral Palsy
CLL
Cirrhosis
Crohn's Disease
Cystic Fibrosis
Depression
Diabetes
Diet
Eczema
Erectile Dysfunction
Fibromyalgia
Genetics
Glioblastoma
Gout
H1N1
H3N2
Hearing Loss
Heart Attack
Hepatitis
Herpes
HIVAIDS
Huntington's Disease
IVF
Lou Gehrig' Disease
Macular Degeneration
Mental Health
Multiple Sclerosis
Neurology
Nutrition
Obesity
Osteoarthritis
Pancreatic Cancer
Parkinson's Disease
Pneumonia
Pregnancy
Prostate Cancer
Retinitis Pigmentosa
Rheumatoid Arthritis
Schizophrenia
Sleep Apnea
Stem Cell
Stroke
Ulcerative Colitis
Vaccine
Virus
Health A-Z
Acne
Alzheimer's Disease
Antioxidant
Arthritis
Asthma
Atrial Fibrillation
Autism
Back Pain
Bipolar Disorder
Breast Cancer
Breastfeeding
Cancer
Cerebral Palsy
Cervical Cancer
Colon Cancer
Cystic Fibrosis
Dementia
Diabetes
Eating Disorder
Eczema
Epilepsy
Fibromyalgia
Folic Acid
Genetics
Glaucoma
Gout
Heart Attack
HIV/AIDS
Hypertension
Immunology
Impotence
Kidney Cancer
Leukemia
Lung Cancer
Malaria
Measles
Menopause
Obesity
Osteoporosis
Ovarian Cancer
Parkinson's Disease
Pediatrics
Prostate Cancer
Retinitis Pigmentosa
Rosacea
Schizophrenia
Skin Cancer
Stem Cell
Tuberculosis
Virus
West Nile Virus
Drugs A-Z
Abilify
Actilyse
Akamin
Amoxil Adult Preparations
Andriol Testocaps
Apo-Amlodipine
Apo-Atenolol
Apo-Clarithromycin
Apo-Clopidogrel
Apo-Gabapentin
Apo-Lansoprazole
Apo-Lisinopril
Apo-Omeprazole
APO-Oxazepam
Apo-Paracetamol Codeine
Apo-Tramadol SR
Arcoxia
Augmentin Syrup
Avil
Avomine
Bactrim
Bactroban Ointment
Bicor
Brufen
Buscopan Tablets
Clexane
Concerta
Coveram
Coversyl
Creon 10000; 25000; and 40000
Daonil
Dilatrend
Duodart
Dynastat
Epilim
Flagyl
Largactil
Lexotan
Lignocaine Injection
Loette
Metrogyl
Monofeme
Motilium
Nausetil
Norgesic
Noriday
Norspan
Norvasc
Nurofen 400 Double Strength
OxyContin
Panadol Cold & Flu Relief Original Formula
Rivotril
Serc
Stemetil
Stieva-A
Telfast
Valium
Voltaren
Zinnat
Zyprexa
Health Products
Autoclaves
Benchtop Sterilizers
Blood Gas Analyzers
Blood Glucose Monitors
Blood Pressure Monitors
CT Scanners
Defibrillators
DNA Sequencing / Analysis Systems
ECG Machines
Fetal Monitors
Fluorometers
Heart Rate Monitors
Hematology Blood Analyzers
Mammography Systems
MRI Scanners
Otoscopes / Auriscopes
Pregnancy Tests
Pulse Oximeters
Spirometers
Stethoscopes
Ultrasound Machines
Vital Signs Monitors
Health Services
Gastric Banding
Hair Transplantation
IVF Clinics
Lasik Eye Surgery
Liposuction
Australian Health Insurance
Canadian Health Insurance
U.S. Health Insurance
UK Health Insurance
News Archive
Info / About
Terms and Conditions
Medical News Letters
Free Magazines
May 27, 2012
Other search tools:
Drugs
|
Health
|
News
About
Terms
Latest News
New, more accurate test for paralytic shellfish poisons
Study: 10 percent of veterans go without health insurance
Muslim women, religious leaders being enlisted in global campaign to eradicate polio
Mass. hospital agrees to $750,000 settlement over 2010 data breach
Overactive BAALC gene found in people with acute leukemia
Senate Appropriations Committee approves FY13 state and foreign operations appropriations bill
Research roundup: Do mandatory screening laws affect disparities?; Mass. health law, 6 years later
Illinois legislature passes bill with deep Medicaid cuts
Special surface allows adult-derived stem cells to thrive and transform into multiple cell types
IPS reports on population and development conference draft declaration
Biotechnology
Blood Pressure
Bone
Brain
Breast Cancer
Cancer
Cell
Chemotherapy
Depression
Diabetes
Diagnostics
Diet
DNA
Education
Exercise
Gene
Genetics
Health and Human Services
Health Insurance
HIV
Hospital
Investment
Medicaid
Medicare
Muscle
Neurology
Neuroscience
Nursing
Nutrition
Obesity
Oncology
Pain
Placebo
Pregnancy
Prostate Cancer
Protein
Stress
Stroke
Translational
Vaccine
Read in |
English
|
Español
|
Français
|
Deutsch
|
Português
|
Italiano
|
日本語
|
한국어
|
简体中文
| 繁體中文 |
العربية
|
Dansk
|
Nederlands
|
Filipino
|
Finnish
|
Ελληνικά
|
עִבְרִית
|
हिन्दी
|
Bahasa
|
Norsk
|
Русский
|
Svenska
|
Magyar
|
Polski
|
Română
|
Türkçe
紅斑狼瘡的事實
Tweet
紅斑狼瘡是身體的慢性的自身免疫性疾病,這將導致各部分,尤其是身體的皮膚、 關節和腎臟炎症。它還可能會影響血液。通常,免疫系統保護身體免受病毒、 細菌和其他外國侵略者。在像紅斑狼瘡自身免疫性疾病,免疫系統失去它能夠告訴外國物質和自己的細胞和組織之間的差異。然後,免疫系統使人體自身抗體。
紅斑狼瘡是不傳染性、 稀有或癌。
雖然紅斑狼瘡的原因是未知的科學家懷疑個人基因易患紅斑狼瘡,並且也知道環境因素,如感染、 抗生素、 紫外線、 極端的壓力和某些藥物發揮關鍵作用,觸發紅斑狼瘡。
紅斑狼瘡罷工成年婦女 10 到 15 倍比成年男性更頻繁。
紅斑狼瘡是非裔美國人、 拉美人和亞洲人中更為普遍。美國黑人婦女是三次更有可能獲得比白人女性紅斑狼瘡。非洲裔美國人和西班牙裔/裔都傾向于發展紅斑狼瘡的年紀和有更多的症狀診斷 (包括腎臟問題)。
只有 10%的人為紅斑狼瘡將有近親屬 (父母或同級) 誰已經已經或可能發展紅斑狼瘡。只有約 5%的兒童出生于個人有紅斑狼瘡會得病。
紅斑狼瘡的人有時經驗"光暈"。當某些症狀短暫出現,然後消失時,將發生這種情況。即使你服用治療紅斑狼瘡,您可能會發現有的時間時症狀變得更糟。認識到 flare 來學習,可以説明您採取步驟,以應付它。很多人覺得很累,或有疼痛、 出疹、 發燒、 胃部不適、 頭痛或只是之前的 flare 頭暈 … …。
紅斑狼瘡可能很難診斷症狀轉來和模仿的許多其它疾病。紅斑狼瘡的一些症狀可能轉瞬即逝,如關節及肌肉疼痛、 疲勞、 引起皮疹或做出更糟的陽光、 低品位發燒、 頭髮損失、 胸膜炎、 食欲,疼痛鼻子、 嘴裡,或痛苦的敏感性的手指在寒冷的環境中。
症狀紅斑狼瘡的範圍可以從溫和到危及生命和成千上萬的美國人死于紅斑狼瘡併發症每年。
使用最佳的護理,大多數女性紅斑狼瘡可以無危害自己的健康有健康的寶寶。
進一步閱讀
紅斑狼瘡是什麼?
紅斑狼瘡症狀
狼瘡診斷
紅斑狼瘡照明彈
紅斑狼瘡治療
紅斑狼瘡和懷孕
紅斑狼瘡和應力
Recent Lupus News
LabCorp, XDx partner to develop and commercialize SLE flare predictor test
XDx, Inc. announced today that it has entered into a collaboration and license agreement with Laboratory Corporation of America Holdings (LabCorp)whereby each party will collaborate in marker discover...
Severe hypersensitivity reactions to anti-HIV drug occur through autoimmune mechanism
Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body'...
Data from Janssen’s SIMPONI Phase 3 study on ulcerative colitis
New study findings presented today show that subcutaneous induction regimens of the anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI (golimumab) induced clinical response in a majority of patien...
Ipsen, Active Biotech complete half of planned recruitment in tasquinimod phase III study for CRPC
Active Biotech and Ipsen today announced that recruitment to the global, pivotal, randomized, double-blind, placebo-controlled phase III study of tasquinimod in patients with metastatic castrate-resis...
Ipsen, Active Biotech to present data from tasquinimod phase II trial on CRPC at ASCO 2012
Active Biotech and Ipsen will present tasquinimod (TASQ), their prostate cancer drug candidate, at the scientific conference "2012 ASCO Annual Meeting" to be held in Chicago (USA) on 1-5 June 2012.